Evaluation of end points of serial drug testing in patients with sustained ventricular tachycardia after healing of acute myocardial infarction

Stan J. Wasilewski, Kevin J. Ferrick, James A. Roth, Soo G. Kim, John Devens Fisher

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Serial electrophysiologic drug testing was used to guide antiarrhythmic therapy in a consecutive series of 150 patients with clinical sustained ventricular tachycardia (VT) or cardiac arrest and inducible monomorphic VT. All patients had coronary artery disease and a history of myocardial infarction. For patients with clinical sustained VT, drug responders and partial drug responders (VT slowed by drug to rate <150 beats/min, with systolic blood pressure ≥90 mm Hg) had similar total mortality rates (2-year actuarial survival 100% and 94%, p = NS), which were statistically different from that or patients with drug inefficacy (2-year survival 67%). Partial drug responders had high arrhythmia recurrence rates, similar to those of patients with drug inefficacy. For cardiac arrest survivors, the results of electrophysiologically guided drug testing did not predict prognosis. Patients with a change in mode or VT induction during antiarrhythmic therapy had a favorable prognosis (no deaths during follow-up).

Original languageEnglish (US)
Pages (from-to)1247-1252
Number of pages6
JournalThe American Journal of Cardiology
Volume76
Issue number17
DOIs
StatePublished - Dec 15 1995

Fingerprint

Ventricular Tachycardia
Myocardial Infarction
Pharmaceutical Preparations
Heart Arrest
Blood Pressure
Survival
Survivors
Cardiac Arrhythmias
Coronary Artery Disease
Recurrence
Mortality
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Evaluation of end points of serial drug testing in patients with sustained ventricular tachycardia after healing of acute myocardial infarction. / Wasilewski, Stan J.; Ferrick, Kevin J.; Roth, James A.; Kim, Soo G.; Fisher, John Devens.

In: The American Journal of Cardiology, Vol. 76, No. 17, 15.12.1995, p. 1247-1252.

Research output: Contribution to journalArticle

@article{b7c29610c99c45b2ad385cd5cb3859af,
title = "Evaluation of end points of serial drug testing in patients with sustained ventricular tachycardia after healing of acute myocardial infarction",
abstract = "Serial electrophysiologic drug testing was used to guide antiarrhythmic therapy in a consecutive series of 150 patients with clinical sustained ventricular tachycardia (VT) or cardiac arrest and inducible monomorphic VT. All patients had coronary artery disease and a history of myocardial infarction. For patients with clinical sustained VT, drug responders and partial drug responders (VT slowed by drug to rate <150 beats/min, with systolic blood pressure ≥90 mm Hg) had similar total mortality rates (2-year actuarial survival 100{\%} and 94{\%}, p = NS), which were statistically different from that or patients with drug inefficacy (2-year survival 67{\%}). Partial drug responders had high arrhythmia recurrence rates, similar to those of patients with drug inefficacy. For cardiac arrest survivors, the results of electrophysiologically guided drug testing did not predict prognosis. Patients with a change in mode or VT induction during antiarrhythmic therapy had a favorable prognosis (no deaths during follow-up).",
author = "Wasilewski, {Stan J.} and Ferrick, {Kevin J.} and Roth, {James A.} and Kim, {Soo G.} and Fisher, {John Devens}",
year = "1995",
month = "12",
day = "15",
doi = "10.1016/S0002-9149(99)80351-8",
language = "English (US)",
volume = "76",
pages = "1247--1252",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "17",

}

TY - JOUR

T1 - Evaluation of end points of serial drug testing in patients with sustained ventricular tachycardia after healing of acute myocardial infarction

AU - Wasilewski, Stan J.

AU - Ferrick, Kevin J.

AU - Roth, James A.

AU - Kim, Soo G.

AU - Fisher, John Devens

PY - 1995/12/15

Y1 - 1995/12/15

N2 - Serial electrophysiologic drug testing was used to guide antiarrhythmic therapy in a consecutive series of 150 patients with clinical sustained ventricular tachycardia (VT) or cardiac arrest and inducible monomorphic VT. All patients had coronary artery disease and a history of myocardial infarction. For patients with clinical sustained VT, drug responders and partial drug responders (VT slowed by drug to rate <150 beats/min, with systolic blood pressure ≥90 mm Hg) had similar total mortality rates (2-year actuarial survival 100% and 94%, p = NS), which were statistically different from that or patients with drug inefficacy (2-year survival 67%). Partial drug responders had high arrhythmia recurrence rates, similar to those of patients with drug inefficacy. For cardiac arrest survivors, the results of electrophysiologically guided drug testing did not predict prognosis. Patients with a change in mode or VT induction during antiarrhythmic therapy had a favorable prognosis (no deaths during follow-up).

AB - Serial electrophysiologic drug testing was used to guide antiarrhythmic therapy in a consecutive series of 150 patients with clinical sustained ventricular tachycardia (VT) or cardiac arrest and inducible monomorphic VT. All patients had coronary artery disease and a history of myocardial infarction. For patients with clinical sustained VT, drug responders and partial drug responders (VT slowed by drug to rate <150 beats/min, with systolic blood pressure ≥90 mm Hg) had similar total mortality rates (2-year actuarial survival 100% and 94%, p = NS), which were statistically different from that or patients with drug inefficacy (2-year survival 67%). Partial drug responders had high arrhythmia recurrence rates, similar to those of patients with drug inefficacy. For cardiac arrest survivors, the results of electrophysiologically guided drug testing did not predict prognosis. Patients with a change in mode or VT induction during antiarrhythmic therapy had a favorable prognosis (no deaths during follow-up).

UR - http://www.scopus.com/inward/record.url?scp=0028806165&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028806165&partnerID=8YFLogxK

U2 - 10.1016/S0002-9149(99)80351-8

DO - 10.1016/S0002-9149(99)80351-8

M3 - Article

C2 - 7503005

AN - SCOPUS:0028806165

VL - 76

SP - 1247

EP - 1252

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 17

ER -